IFNG and Hepatic fibrosis: Mechanistically, LPS/IFN‐γ treated macrophages have a better ability to recruit host innate immune cells to relieve liver fibrosis synergistically.[9] However, because LPS is the quintessential endotoxin and may induce systemic inflammation, its side effects and toxicities might restrict its clinical application.